Ms. Jyothirmai, Director of Megsan Labs, has announced that Megsan now offers special capabilities to support pharmaceutical clients on nitrosamines as per USFDA and EMEA guidelines, using six GCMS and three LCMS devices.  

Currently, Megsan Labs serve all major pharmaceutical companies across India to support them with regulatory issues.With its excellent scientific team, they develop and validate methods according to regulatory requirements.

Megsan Labs has hands on experience in evaluating the inner surface durability of glass containers as per USP 1660. These containers are used in various aqueous liquid formulations in glass delamination studies. They support the regulatory applications of various customers, by using advanced techniques such as ICPMS, SEM, and Inverted Microscopes.

Megsan develops and validates the quantification methods for >24 elemental impurities as per ICH Q3D and USP 232 studies for >500 various parenteral and oral products sample matrices. Examples of these matrices are raw materials, active pharmaceutical products, and pharmaceutical products such as tablets, capsules, injections, oral suspensions and other formulations for customers. Furthermore, Megsan conductsscreening studies for 40+ elemental impurities and supports customers in their risk assessments.

Note from Mr. Jayapal Reddy, CEO: “We look forward to adding other verticals at Megsan such as Medical Device Testing as per ISO 17025 for Chemical and Microbiology areas. Also, we’re planning to establish a new business unit ‘Megsan Diagnostics’ which will be active in the diagnostics, pharmacy, retail and clinics chain.”

About Megsan Labs

Megsan is a US-FDA Inspected & approved, ISO 17025 Accredited, FSSAI approved and DCGI (Drug Controller General of India -Indian FDA) approved Laboratory, which provides analytical testing services to pharmaceutical and related companies. The services comprise elemental impurity studies, E&L studies, method development & validation and microbiological testing.

Jayapal Reddy and Jyothirmai founded the company in 2012. Today Megsan employs more than 140 people. For more information, please visit www.megsanlabs.com

Über die Tentamus Group GmbH

Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrosciences, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 65 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.

Tentamus Group
An der Industriebahn 5
13088 Berlin, Germany
www.tentamus.com

Firmenkontakt und Herausgeber der Meldung:

Tentamus Group GmbH
An der Industriebahn 26
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
https://www.tentamus.com

Ansprechpartner:
Jyothirmai Madireddy
Director of Megsan Labs
Telefon: 040 30272727, Ext.: 5108.
E-Mail: m.jyothirmai@megsanlabs.com
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel